BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28040445)

  • 1. The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial.
    Shiomi H; Morimoto T; Kitaguchi S; Nakagawa Y; Ishii K; Haruna Y; Takamisawa I; Motooka M; Nakao K; Matsuda S; Mimoto S; Aoyama Y; Takeda T; Murata K; Akao M; Inada T; Eizawa H; Hyakuna E; Awano K; Shirotani M; Furukawa Y; Kadota K; Miyauchi K; Tanaka M; Noguchi Y; Nakamura S; Yasuda S; Miyazaki S; Daida H; Kimura K; Ikari Y; Hirayama H; Sumiyoshi T; Kimura T;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):109-117. PubMed ID: 28040445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study.
    Biscaglia S; Tebaldi M; Brugaletta S; Cerrato E; Erriquez A; Passarini G; Ielasi A; Spitaleri G; Di Girolamo D; Mezzapelle G; Geraci S; Manfrini M; Pavasini R; Barbato E; Campo G
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2079-2088. PubMed ID: 31563688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
    Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical and angiographic results of hybrid coronary revascularization.
    Modrau IS; Holm NR; Mæng M; Bøtker HE; Christiansen EH; Kristensen SD; Lassen JF; Thuesen L; Nielsen PH;
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1181-6. PubMed ID: 26432721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.
    Güngör B; Alper AT; Ozcan KS; Ekmekçi A; Karadeniz FÖ; Mutluer FO; Kaya A; Karataş B; Osmonov D; Bolca O
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):965-72. PubMed ID: 24402881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main.
    Aurigemma C; Burzotta F; Porto I; Niccoli G; Leone AM; Crea F; Trani C
    Cardiol J; 2018; 25(5):582-588. PubMed ID: 30155864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
    Smits PC; Vlachojannis GJ; McFadden EP; Royaards KJ; Wassing J; Joesoef KS; van Mieghem C; van de Ent M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1157-1165. PubMed ID: 26210806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical Presentation in Patients Undergoing Complex PCI.
    Lee SY; Choi KH; Kim CJ; Lee JM; Song YB; Lee JY; Lee SJ; Lee SY; Kim SM; Yun KH; Cho JY; Ahn HS; Nam CW; Yoon HJ; Park YH; Lee WS; Jeong JO; Song PS; Kim SE; Doh JH; Jo SH; Yoon CH; Kang MG; Koh JS; Lee KY; Lim YH; Cho YH; Cho JM; Jang WJ; Chun KJ; Hong D; Park TK; Yang JH; Choi SH; Gwon HC; Hahn JY;
    JACC Cardiovasc Interv; 2024 May; 17(10):1231-1243. PubMed ID: 38811104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study.
    Prati F; Di Vito L; Biondi-Zoccai G; Occhipinti M; La Manna A; Tamburino C; Burzotta F; Trani C; Porto I; Ramazzotti V; Imola F; Manzoli A; Materia L; Cremonesi A; Albertucci M
    EuroIntervention; 2012 Nov; 8(7):823-9. PubMed ID: 23034247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Coherence Tomography-Guided Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Prospective Propensity-Matched Cohort of the Thrombectomy Versus Percutaneous Coronary Intervention Alone Trial.
    Sheth TN; Kajander OA; Lavi S; Bhindi R; Cantor WJ; Cheema AN; Stankovic G; Niemelä K; Natarajan MK; Shestakovska O; Tittarelli R; Meeks B; Jolly SS
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003414. PubMed ID: 27056766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.